GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Greater Cannabis Co Inc (OTCPK:GCAN) » Definitions » EBITDA Margin %

Greater Cannabis Co (Greater Cannabis Co) EBITDA Margin % : 0.00% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Greater Cannabis Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Greater Cannabis Co's EBITDA for the three months ended in Mar. 2024 was $-0.04 Mil. Greater Cannabis Co's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, Greater Cannabis Co's EBITDA margin for the quarter that ended in Mar. 2024 was 0.00%.


Greater Cannabis Co EBITDA Margin % Historical Data

The historical data trend for Greater Cannabis Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greater Cannabis Co EBITDA Margin % Chart

Greater Cannabis Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial -16,128.57 331.25 -2,384.62 - -

Greater Cannabis Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Greater Cannabis Co's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Greater Cannabis Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greater Cannabis Co's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greater Cannabis Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Greater Cannabis Co's EBITDA Margin % falls into.



Greater Cannabis Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Greater Cannabis Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-0.17/0
= %

Greater Cannabis Co's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-0.038/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Greater Cannabis Co  (OTCPK:GCAN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Greater Cannabis Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Greater Cannabis Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Greater Cannabis Co (Greater Cannabis Co) Business Description

Traded in Other Exchanges
N/A
Address
15 Walker Avenue, Suite 101, Baltimore, MD, USA, 21208
Greater Cannabis Co Inc ia a biopharmaceutical company focused on the development and commercialization of innovative cannabinoid therapeutics. The firm focuses on cannabis-related investment and development opportunities through direct equity investments, joint ventures, licensing agreements, or acquisitions and also on commercializing its eluting transmucosal patch platform (ETP) technology. The company's operations are focused on its online store, GCC Superstore. The firm is involved in additional research and development of innovative cannabinoid-based therapeutics.
Executives
Jimmy Wayne Anderson 10 percent owner 501 1ST AVENUE NORTH, SUITE 901, ST. PETERSBURG FL 33701